“A Case Report on Prolonged Response with Trastuzumab Emtansine (T-DM1) in Recurrent Advance Breast Cancer Setting” (2023) Journal of Cancer Research Updates, 12, pp. 49–53. doi:10.30683/1929-2279.2023.12.9.